INTERPACE BIOSCIENCES, INC. Annual Cost of Revenue in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
Interpace Biosciences, Inc. quarterly/annual Cost of Revenue history and growth rate from 2014 to 2023.
  • Interpace Biosciences, Inc. Cost of Revenue for the quarter ending September 30, 2024 was $4.79M, a 16.1% increase year-over-year.
  • Interpace Biosciences, Inc. Cost of Revenue for the twelve months ending September 30, 2024 was $17.7M, a 14.6% increase year-over-year.
  • Interpace Biosciences, Inc. annual Cost of Revenue for 2023 was $16.3M, a 19.9% increase from 2022.
  • Interpace Biosciences, Inc. annual Cost of Revenue for 2022 was $13.6M, a 4.94% decline from 2021.
  • Interpace Biosciences, Inc. annual Cost of Revenue for 2021 was $14.3M, a 34% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $16.3M +$2.7M +19.9% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-01
2022 $13.6M -$707K -4.94% Jan 1, 2022 Dec 31, 2022 10-K 2024-04-01
2021 $14.3M -$7.36M -34% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-27
2020 $21.7M +$5.79M +36.4% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $15.9M +$5.69M +55.8% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-01
2018 $10.2M +$2.84M +38.6% Jan 1, 2018 Dec 31, 2018 10-K/A 2021-01-19
2017 $7.36M +$717K +10.8% Jan 1, 2017 Dec 31, 2017 10-K 2018-03-23
2016 $6.64M -$269K -3.89% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-23
2015 $6.91M +$5.64M +445% Jan 1, 2015 Dec 31, 2015 10-K 2017-03-31
2014 $1.27M Jan 1, 2014 Dec 31, 2014 10-K 2016-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.